Company Overview and News

14
H&R Block Inc Stock Could Be the Perfect Addition for Income Investors

2018-06-15 investorplace
H & R Block Inc (NYSE:HRB) plunged in morning trading recently. The Kansas City-based tax preparation firm fell despite an earnings beat. Price cuts designed to “appeal to customers” did not likewise appeal to potential investors in HRB stock.
INTU TGT HRB

4
H&R Block Continues To Bleed: Future Tied To Success Or Failure Of New Strategy

2018-06-15 seekingalpha
H&R Block (NYSE:HRB) is struggling against the reality that any market sector that can be disrupted digitally, will be. For that reason the company was hammered recently after its earnings report, as the market wasn't impressed with its failure to buy back share, or its lowered EBITDA margin guidance as it boosts spending in an attempt to differentiate from its competitors in an increasingly commoditized business.
INTU HRB

81
Proceed With Caution With Square Inc Stock

2018-06-14 investorplace
Square Inc (NYSE:SQ), the payment play from Twitter Inc (NYSE:TWTR) founder Jack Dorsey, has gained 400% in just 2.5 years on the New York Stock Exchange. It’s now worth $25 billion. This year alone, shares have almost tripled, rising from $23 to $63.
WFC WFCNP WFC.WS SQ SQNXF WFC.PRL DTK PYPL WFC.PRJ WFC.PRT INTU WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN TWTR FDC WFC.PRY WFC.PRX WFC.PRW WFC.PRV

5
Verint Systems (VRNT) Hits Fresh Highs: Is There Still Room to Run?

2018-06-13 zacks
Have you been paying attention to shares of Verint Systems (VRNT - Free Report) ? Shares have been on the move with the stock up 8.4% over the past month. VRNT hit a new 52-week high of $45.40 in the previous session. Verint Systems has gained 8.2% since the start of the year compared to the 9.5% move for the Computer and Technology sector and the 18.3% year-to-date return for its peer group.
INTU VRNT KMG CTXS URBN EPAY

121
Tech Companies Still Aren’t Hiring Black Workers - Bloomberg

2018-06-08 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
FB INTU DVMT GOOGL OCLCF MSFT GOOG DIS ORCL

145
Some fund managers are avoiding Amazon as it leads U.S. market

2018-06-07 reuters
NEW YORK (Reuters) - For most U.S. fund managers, beating the market this year has come down to one decision: whether or not to own shares of Amazon.com Inc (AMZN.O).
BRK.A INTU ALGN MA ABMD RHT ADBE

178
Intuit (INTU) Touches 52-Week High on Impressive Q3 Results

2018-06-07 zacks
Shares of Intuit Inc. (INTU - Free Report) rallied to a new 52-week high of $209.54, eventually closing at $209.50 on Jun 6. This rise in share price can be primarily attributed to better-than-expected third-quarter fiscal 2018 results on the back of a successful tax season. Earnings and revenues also recorded year-over-year improvement. Intuit’s revenues of $2.925 billion jumped 15% year over year and non-GAAP earnings of $4.
INTU MU WDC NVDA

4
Bottomline Technologies (EPAY) Soars to a 52-Week High, Time to Cash Out?

2018-06-07 zacks
Have you been paying attention to shares of Bottomline Technologies (EPAY - Free Report) ? Shares have been on the move with the stock up 12.7% over the past month. EPAY hit a new 52-week high of $50.01 in the previous session. Bottomline Technologies has gained 44.1% since the start of the year compared to the 9.6% move for the Computer and Technology sector and the 18.5% year-to-date return for its peer group.
SAP INTU SAPGF CTXS EPAY

3
Alumni elect first Fil-Am to Harvard board of overseers

2018-06-06 usa.inquirer.net
SAN FRANCISCO — Geraldine Acuña-Sunshine has been elected to Harvard University’s Board of Overseers, along with five others, the Harvard Alumni Association (HAA), announced. She is the first Filipina to be a member of the Board of Overseers
INTU

192
Microsoft expands program for women returning to work

2018-06-06 channelnewsasia
Microsoft Corp is expanding a program designed to increase its hiring of women seeking to rejoin the workforce, following a rash of complaints about sexual harassment and gender discrimination at the world's largest software company.
INTU AAPL MSFT PYPL

193
CORRECTED-Microsoft expands program for women returning to work

2018-06-06 reuters
SAN FRANCISCO, June 5 (Reuters) - Microsoft Corp is stepping up its hiring of women seeking to rejoin the workforce, following a rash of complaints about sexual harassment and gender discrimination at the world’s largest software company.
INTU AAPL MSFT PYPL

192
Microsoft expands programme for women returning to work

2018-06-06 channelnewsasia
Microsoft Corp is expanding a program designed to increase its hiring of women seeking to rejoin the workforce, following a rash of complaints about sexual harassment and gender discrimination at the world's largest software company.
INTU AAPL MSFT PYPL

192
Microsoft launches program for women returning to work

2018-06-05 channelnewsasia
SAN FRANCISCO: Microsoft Corp is stepping up its hiring of women seeking to rejoin the workforce, following a rash of complaints about sexual harassment and gender discrimination at the world's largest software company.
INTU AAPL MSFT PYPL

192
Microsoft launches program for women returning to work

2018-06-05 reuters
SAN FRANCISCO (Reuters) - Microsoft Corp is stepping up its hiring of women seeking to rejoin the workforce, following a rash of complaints about sexual harassment and gender discrimination at the world’s largest software company.
INTU AAPL MSFT PYPL

51
Zacks.com highlights: Shoe Carnival, Arrow Electronics, Lithia Motors, Grand Canyon Education and Intuit

2018-06-05 zacks
Chicago, IL – June 5, 2018 - Stocks in this week’s article include: Shoe Carnival, Inc. (SCVL - Free Report) , Arrow Electronics, Inc. (ARW - Free Report) , Lithia Motors, Inc. (LAD - Free Report) , Grand Canyon Education, Inc. (LOPE - Free Report) and Intuit Inc. (INTU - Free Report) .
LOPE TOL NWDVW WDC NYTAB FITBI CFIN CFG XEL INTU DQ CIWV SCVL ARW FITB NEWM LAD

Related Articles

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

3h - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

PRTO: Proteon Therapeutics Analysis and Research Report

2018-06-11 - Asif

Overview Proteon Therapeutics is a late-stage biopharmaceutical company focused on the development of novel, first-in-class pharmaceuticals to address the needs of patients with renal and vascular disease. The company's product candidate, vonapanitase, is a recombinant human elastase that Proteon Therapeutics is developing to improve vascular access outcomes in patients with chronic kidney disease, or CKD, undergoing or planning for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. The company believe data from its completed Phase 2 and Phase 3 clinical trials of vonapanitase support that a one-time, local application of investigational vonapanitase during surgical creation of a radiocephalic fistula for hemodialysis may improve fistula use for hemodialysis and secondary patency (time to fistula abandonment), thereby improving patient outcomes and reducing the burden on patients and the healthcare system. Arteriovenous fistu...

GALE: Galena Biopharma Analysis and Research Report

2018-06-11 - Asif

Overview Galena Biopharma is a clinical-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, or GPS, is a cancer i unotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, that targets the Wilms tumor 1, or WT1, protein, which is present in 20 or more cancer types. Based on its mechanism of action as a directly immunizing agent, GPS has the potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic, or blood, cancers and solid tumor indications. Phase 2 clinical trials for GPS have been completed and Galena Biopharma has planned Phase 3 clinical trials (pending funding availability) for two indications, acute myeloid leukemia, or AML, and malignant pleural mesothelioma, or MPM. GPS is also in development as a potential treatment for multiple myeloma, or MM, and ovarian can...

Silicon Investor Message Boards

This table lists all message boards related to INTU / Intuit Inc. on message board site Silicon Investor.

Intuitive Surgical, Inc. (ISRG) Quicken - Problems and Answers....
Intuit -- Whatu0027s Its Future? I need to quintuple $20,000
Intuit Quintus (QNTS)
ISRG - Intuitive Surgical Intuition
INTUIT - Will it die? Quintus Corp.
CUSIP: 461202103